官方服务：
资源简介：
Faster insulin aspart in type 1 diabetes mellitus
应用场景：
创建时间：
2022-03-31
相关数据集
Global Insulin Biosimilars Market Size, Share, Growth Analysis, By Type(Fast-acting Insulin, Intermediate-acting Insulin), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies), By Indication(Diabetes Type 1, and Diabetes Type 2) - Industry Forecast 2024-2031
Global Insulin Biosimilars Market size was valued at USD 2.67 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 4.07 billion by 2031, growing at a CAGR of 4.8% in the forecast
www.skyquestt.com60
Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2
Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2 Descriptor: ACETATE ION, INSULIN A CHAIN, INSULIN B CHAIN Authors: Brzozowski, A.M, Jiracek, J, Zakova, L, Antolikova, E, Wats
Protein Data Bank Japan2023-12-20 更新50
Clinical Islet Transplantation Consortium (CITC)
The CIT consortium conducted a total of 9 studies across North America (CIT02 through CIT08) and the Nordic region (CIT01). CIT08 was a long-term follow-up study for interested participants at the Nor
Immunology Database and Analysis Portal2025-10-30 更新30
Insulin with proline analog PiP at position B28 in the R6 state
Insulin with proline analog PiP at position B28 in the R6 state Descriptor: CHLORIDE ION, Insulin Chain A, Insulin Chain B, ... Authors: Lieblich, S.A, Fang, K.Y, Tirrell, D.A. Deposit date: 2017-02-1
Protein Data Bank Japan2024-11-06 更新50
Physicochemical properties of insulin analogs.
Physicochemical properties of insulin analogs.
NIAID Data Ecosystem50
